Searchable abstracts of presentations at key conferences in endocrinology

ea0012oc24 | Pituitary, ovary and steroids | SFE2006

Influence of C-type natriuretic peptide (CNP) on cell proliferation in αT3-1 gonadotrophs and GH3 somatotrophs

Thompson IR , Jonas KC , Wolf S , Lawson C , Wheeler-Jones CP , Fowkes RC

C-type natriuretic peptide (CNP) acts via its specific membrane-bound guanylyl cyclase receptor, GC-B, to stimulate cGMP production. Stimulation of cGMP impinges upon PKG and PKA signalling, leading to cell proliferation and cell cycle events. In endothelial cells, CNP is thought to perform a predominantly anti-mitogenic role, but the role of CNP on cell proliferation, cell cycle and DNA synthesis in pituitary cell lines has yet to be established. Using the mouse gonadotroph-d...

ea0004oc14 | Endocrine tumours and neoplasia | SFE2002

ANGIOTENSIN II INDUCES C-FOS EXPRESSION THROUGH PKC-zeta IN MCF-7 BREAST CANCER CELL LINE

Muscella A , Greco S , Elia M , Storelli C , Marsigliante S

It has been reported that Ang II induces the growth of MCF-7 breast cancer cells (Muscella et al., J Endocrinol 173, 315-323, 2002). Here we have examined the signalling pathways evoked by Ang II in MCF-7. Ang II did not change the concentration of intracellular calcium but induced the cytosol-to-membrane translocation of atypical protein kinase C zeta (PKC-zeta). Ang II dose-dependently induced c-fos (mRNA and protein) and enhanced the phosphorylation state of extracellular s...

ea0029p667 | Diabetes | ICEECE2012

Cardiorespiratory fitness is decreased and not correlated with C-Reactive Protein levels in adults with Diabetes Mellitus

Francisco C. , Catai A. , Moura S. , Lopes S. , Del Vale A. , Leal A.

Diabetes Mellitus (DM) has been associated with lung dysfunction and impairment of cardiorespiratory fitness and increasing evidences have suggested that comorbidities and systemic inflammation may be involved in these derangements. However, the results regarding cardiopulmonary dysfunction and its underlying mechanisms in DM are still controversial. In this study, we evaluated the relationship between metabolic variables and inflammation marker, including hemoglobin A1C (HbA1...

ea0002p43 | Endocrine tumours and neoplasia | SFE2001

Variable expression of IGF-1 in breast cancer influences expression of c-myc and Cox-2

Laban C , Ogunkolade W , Kirkpatrick K , Bustin S , Mokbel K , Ghilichik M , Carpenter R , Jenkins P

Background: IGF-1 is a ubiquitous growth factor that has been shown to play an important role in breast tissue development and tumorigenesis. Previously we have shown that IGF-1 expression is lost in approximately 1/3 of breast carcinomas. It is unsure whether this indicates the existence of a subset of breast cancers that may behave differently clinically and on a molecular level. Aims: To assess and quantify the mRNA expression of (i) Cox-2 and c-myc, genes imp...

ea0090p102 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

People With Newly Diagnosed T2DM Showed Significant Improvement in Glycemic Control and Effective Weight Management After Completion of Fitterfly Diabetes Digital Therapeutics Program

Lathia Tejal , Verma Ritika , Khader Mohammed Abdul , Selvan Chitra , C S Dwarakanath , Aggarwal Ajay , Ghanekar Gayatri , Bansal Beena , Goyal Ramesh , Joshi Shilpa , Singal Arbinder

Background and aim: Early glycemic control and weight reduction in diabetes has been associated with prevention of progression of β-cell dysfunction and reduction in diabetes-related complications. Digital therapeutics (DTx) platforms can provide evidence-based therapeutic interventions to improve glycemic control using sustainable behavior change. This study aims at assessing the real-world effectiveness of the Fitterfly Diabetes program in improving glycemic control and...

ea0019p353 | Thyroid | SFEBES2009

Thyroid dysfunction in a Hepatitis C population treated with interferon therapy

Costelloe S , Wassef N , Morris C , Schulz J , Vaghjani T , Thomas M , Jacobs M , Dusheiko G , Vanderpump M

Interferon alpha (IFNα) and Ribavirin combination therapy effectively eradicates Hepatitis C Virus (HCV) in up to 80% of patients. Transient thyroid dysfunction (TD) (>80% hypothyroidism) usually due to a destructive thyroiditis has been recognised to occur in up to 25% of patients treated in Italy, Japan and Australia. However, data are lacking in a UK cohort and no standardised protocol for testing of thyroid function testing exists. The aim of this study was to det...

ea0029p847 | Endocrine tumours and neoplasia | ICEECE2012

Clinical and morphological characterization of C cell hyperplastic and neoplastic lesions of thyroid

Lugli F. , Fusco A. , Bianchi A. , Milardi D. , Cimino V. , Piacentini S. , Celico M. , Lanza P. , Raffaelli M. , Lombardi C. , Fadda G. , Bellantone R. , Pontecorvi A. , Rindi G. , De Marinis L.

Introduction: Medullary thyroid carcinoma (MTC) and C cell hyperplasia (CCH) have a variable clinical presentation and prognosis and few data are available on the correlation between immunohistochemical characterization (IIC) and clinical behavior.Aim: We studied the clinical and morphological characterization of CCH and MTC and we evaluated IIC expression of PTTG-1, SSTR2A, VEGFR-1, VEGFR-2 and VEGFR-3 in 23 cases of CCH and/or MTC, correlating it with ...

ea0026p426 | Thyroid (non cancer) | ECE2011

Triiodothyronine stimulates cystatin C production and glucose transport in bone cells

Schmid Ch , Ghirlanda C , Zwimpfer C

Background: Thyroid hormones increase both serum levels of cystatin C and renal glomerular filtration rate (reflected by lower serum creatinine); the latter is considered the main determinant of cystatin C levels. A potential explanation for this apparently discrepant finding is an increased production, rather than a decreased clearance, of cystatin C. To study whether 3,3′,5-triiodo-L-thyronine (T3) increases the production of cystatin C in a w...

ea0011p96 | Clinical case reports | ECE2006

A case of Cushing’s syndrome and rapid course of illness

Sudagani J , Jacob K , Anwar S , Gibson C , Davis JRE , Wu FCW

A 68-year-old woman presented with hypertension, oedema, weight gain and moon face. She had signs of proximal muscle weakness, thinning of scalp hair and bruising on her legs. Initial tests showed 24 hour urine free cortisol elevated at 946 nmol (0–300 nmol).Serum cortisol showed no circadian fluctuation (0900: 1094 nmol/l, 2400 hrs: 886 nmol/l) and no suppression by dexamethasone (2 mg/24 h for 48 h: 1067 nmol/l). ACTH levels were slightly raised (...

ea0011p377 | Diabetes, metabolism and cardiovascular | ECE2006

Frequency of dyslipidemiαs in children – results of lifestyle intervention

Petrou VA , Tertipi AK , Posnaghidou E , Kostakioti ED , Skarpa VT , Anastasakou M , Hadjiathanasiou C

Dyslipidemiαs should be managed from childhood for prevention of early atheromatic vascular lesions and premature cardiovascular disease in adult life.Aim: We examined the frequency of different types of dyslipidemiα in children and the results on blood lipids of lifestyle intervention (diet and exercise).Patients and methods: We studied retrospectively 136 children, 74 boys and 62 girls, mean chronological age 8.5±3...